The effect of S-ademetionine on plasma citrulline level during chemotherapy-induced oxidative stress in patients with chronic lymphoproliferative disorders
dc.contributor.author | Skrypnyk, R. І. | |
dc.contributor.author | Maslova, G. S. | |
dc.contributor.author | Skrypnyk, I. N. | |
dc.contributor.author | Скрипник, Роман Ігорович | |
dc.contributor.author | Маслова, Ганна Сергіївна | |
dc.contributor.author | Скрипник, Ігор Миколайович | |
dc.date.accessioned | 2022-10-03T08:07:51Z | |
dc.date.available | 2022-10-03T08:07:51Z | |
dc.date.issued | 2022-06 | |
dc.description.abstract | The aim: To investigate the effect of S-ademetionine on plasma citrulline level in patients with chronic lymphoproliferative disorders (CLPD) during chemotherapy-induced oxidative stress. Materials and methods: 25 patients with CLPD were examined. Examinations were conducted twice: before chemotherapy (CT) and after 3 courses of CT. Several biochemical markers in the blood were determined: the activity of catalase, the level of plasma citrulline, the concentration of N-acetylneuraminic acid (NANA) and the concentration of substances that form a trimethine complex (TBARS) with 2-thiobarbituric acid. Patients were divided into groups: І (n=14) – patients who underwent only CT; ІІ (n=16) – patients who during CT received S-ademetionine, at a dose of 1000 mg/day intravenously for 10 days, then 500 mg twice a day for 20 days. ІІІ (n=20) –the control group of 20 practically healthy individuals. Results: Patients in both groups with CLPD had pre-existed mucosal injury that was characterized by 1.25 (p=0.0025) and 1.26 times (р=0.006) higher blood NANA concentration compared to the control group. The conduction of CT was associated with enterocytes dysfunction, which was characterized by 1,66 times (p=0,0002) lower plasma citrulline level in patients of group I compared to the initial examination. The infusion of S-ademetionine attenuated intestinal dysfunction that was associated with 1,23 times (p=0,0005) higher blood citrulline level after the CT as compared to group I. Conclusions: The infusion of S-ademetionine as adjuvant treatment in patients with CLPD provided effective prophylaxis of intestinal injury that was associated with higher blood citrulline level after the conduction of CT. | uk_UA |
dc.identifier.citation | Skrypnyk R. І. The effect of S-ademetionine on plasma citrulline level during chemotherapy-induced oxidative stress in patients with chronic lymphoproliferative disorders / R. І. Skrypnyk, G. S. Maslova, I. N. Skrypnyk // Wiadomosci Lekarskie. – 2022. – Vol. LXXV, issue 6. – P. 1553–1557. | uk_UA |
dc.identifier.doi | 10.36740/WLek202206123 | |
dc.identifier.uri | https://repository.pdmu.edu.ua/handle/123456789/19060 | |
dc.language.iso | en | uk_UA |
dc.publisher | Aluna Publishing | uk_UA |
dc.subject | S-ademetionine | uk_UA |
dc.subject | mucositis | uk_UA |
dc.subject | oxidative stress | uk_UA |
dc.subject | citrulline | uk_UA |
dc.title | The effect of S-ademetionine on plasma citrulline level during chemotherapy-induced oxidative stress in patients with chronic lymphoproliferative disorders | uk_UA |
dc.type | Article | uk_UA |
Файли
Контейнер файлів
1 - 1 з 1
Ескіз недоступний
- Назва:
- the_effect_of_s-ademetionine_on_plasma.pdf
- Розмір:
- 672.86 KB
- Формат:
- Adobe Portable Document Format
- Опис:
Ліцензійна угода
1 - 1 з 1
Ескіз недоступний
- Назва:
- license.txt
- Розмір:
- 4.3 KB
- Формат:
- Item-specific license agreed upon to submission
- Опис: